New and updated preclinical data presented at the American Association for Cancer Research annual meeting in Orlando, Fla., by: Abclon, Affimed, Ascentage Pharma, Ashvattha Therapeutics, Black Diamond Therapeutics, Elevation Oncology, Exuma Biotech, Flare Therapeutics, Halda Therapeutics, Harpoon Therapeutics, Imvax, Innocare Pharma, Lassen Therapeutics, Medigene, Myeloid Therapeutics, Monte Rosa Therapeutics, Myricx Pharma, Nkarta, Nurix Therapeutics, Nuvalent, Onquality Pharmaceuticals, Phio Pharmaceuticals, Qualigen, Surface Oncology, Theratechnologies, Vincerx Pharma, Xencor.